Showing results (11-20 of 86) with videos related to
Sort By:
Pageof 9
Expert Review of Molecular Diagnostics|September 21, 2017
Diagnostic and prognostic cytogenetics of chronic myeloid leukaemia: an updateMatteo Molica, Fulvio Massaro, Massimo BrecciaExpert Review of Anticancer Therapy|November 19, 2025
Ropeginterferon alfa-2b in polycythemia vera: redefining disease control through molecular targetingLaura De Fazio, Matteo Molica, Marco RossiJournal of Clinical Medicine|March 27, 2025
Integrating Blinatumomab in the Frontline Treatment in B-Cell Acute Lymphoblastic Leukemia: A New Era in Therapeutic ManagementMartina Canichella, Laura De Fazio, Matteo MolicaJournal of Clinical Medicine|November 9, 2024
Evaluating Fitness in Older Acute Myeloid Leukemia Patients: Balancing Therapy and Treatment RisksMatteo Molica, Martina Canichella, Elias Jabbour, et al.Expert Opinion on Pharmacotherapy|July 4, 2014
Azacitidine for myelodysplastic patients aged > 65 years: a review of clinical efficacyMassimo Breccia, Matteo Molica, Irene Zacheo, et al.Expert Opinion on Drug Safety|January 23, 2016
Adverse events associated with tyrosine kinase inhibitors for the treatment of chronic myeloid leukemiaMassimo Breccia, Gioia Colafigli, Matteo Molica, et al.Expert Review of Hematology|March 10, 2018
Novel tyrosine-kinase inhibitors for the treatment of chronic myeloid leukemia: safety and efficacyFulvio Massaro, Gioia Colafigli, Matteo Molica, et al.Oncotargets and Therapy|April 10, 2013
Systematic review of dasatinib in chronic myeloid leukemiaMassimo Breccia, Adriano Salaroli, Matteo Molica, et al.Expert Review of Hematology|April 28, 2015
Improvement of bone marrow fibrosis with ruxolitinib: will this finding change our perception of the drug?Massimo Breccia, Matteo Molica, Gioia Colafigli, et al.Leukemia Research|July 27, 2024
The impact of different FLT3-inhibitors on overall survival of de novo acute myeloid leukemia: A network meta-analysisMatteo Molica, Salvatore Perrone, Marco Rossi, et al.Pageof 9